Puget Sound Business Journal, September 2025

Puget Sound Business Journal reports on PNRI’s decision to list our longtime Seattle headquarters for $9.5 million while exploring future space options.

Science in Seattle, September 2025

Science in Seattle: PNRI’s 2025 SURI interns take the stage—eight projects, new skills, and big discoveries.

Science in Seattle, July 2025

Science in Seattle spotlights PNRI’s leadership transition—celebrating CEO Jack Faris, PhD’s service and welcoming Mark Rieder, PhD as our new COO.

The Seattle Times, February 2025

The Seattle Times published an op-ed by PNRI CEO, Jack Faris, PhD, and Interim Chief Scientific Officer & Senior Investigator, Aimée Dudley, PhD, highlighting the real-world consequences of when federal research funding is disrupted—not just for scientists, but for the millions of people waiting for a diagnosis, treatment, or cure.

Science in Seattle, December 2024

Science in Seattle spotlights PNRI’s six new trustees—leaders in science, business, finance, governance, and patient advocacy.

Science, September 2024

Dr. Michael Metzger weighs in on recent research into transmissible cancer in hydras, connecting it to his lab’s work on contagious cancers in shellfish. He shares insights on how these findings contribute to understanding cancer’s evolution across species.

Metzger Lab

Science in Seattle, August 2024

Science in Seattle spotlights PNRI’s largest SURI class yet—ten undergrads diving into real lab research with PI mentors.

Science in Seattle, August 2024

Science in Seattle spotlights PNRI’s podcast launch: Jack and Anna Faris dive into the people and surprises behind genetics research.

Science in Seattle, June 2024

Science in Seattle recaps PNRI’s first Rare Disease Hackathon—an international sprint to find disease-causing variants for undiagnosed families.

Science in Seattle, May 2024

Science in Seattle takes you inside PNRI’s open house—live lab demos, clam cancer research, and TEDDY’s T1D insights.